Nanoemulsified green tea extract shows improved hypocholesterolemic effects in C57BL/6 mice

Journal of Nutritional Biochemistry

Volumn 23, Issue 2, 2012, Pages 186-191

  Kim, Young Jun ^a,b   Houng, Soung Jin ^a   Kim, Jae Hoon ^a   Kim, Young Rok ^c   Ji, Hong Geun ^d   Lee, Sung Joon ^a  

^a Korea University   (South Korea)

^b Department of Obstetrics Gynecology   (United States)

^c Kyung Hee University   (South Korea)

^d H and A Pharmachem   (South Korea)

Author keywords

Antioxidant; Bioavailability; Green tea; Hypolipidemia; Nanoemulsification

Indexed keywords

2,2' AZINO BIS(3 ETHYLBENZTHIAZOLINE 6 SULFONIC ACID); ANTIOXIDANT; CATECHIN; CHOLESTEROL 7ALPHA MONOOXYGENASE; DICHLOROFLUORESCEIN; GREEN TEA EXTRACT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; NANOEMULSIFIED GREEN TEA EXTRACT; NIOSOME; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; ASSAY; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; GENE EXPRESSION; LIPID DIET; LIVER; MALE; MOUSE; NANOEMULSION; NONHUMAN; PROTEIN EXPRESSION; RADICAL SCAVENGING ASSAY;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTIOXIDANTS; CAMELLIA SINENSIS; CHOLESTEROL 7-ALPHA-HYDROXYLASE; CHOLESTEROL, LDL; DIET, HIGH-FAT; DOWN-REGULATION; EMULSIONS; GENE EXPRESSION REGULATION; HYDROXYMETHYLGLUTARYL COA REDUCTASES; LIPIDS; MALE; MICE; MICE, INBRED C57BL; NANOTECHNOLOGY; PLANT EXTRACTS; STEROL REGULATORY ELEMENT BINDING PROTEIN 2;

MUS;

EID: 84855493985     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.11.015     Document Type: Article

References (25)

1. Cabrera C., Artacho R., Gimenez R. Beneficial effects of green tea - a review. J Am Coll Nutr 2006, 25:79-99.
2. Hertog M.G., Sweetnam P.M., Fehily A.M., Elwood P.C., Kromhout D. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr 1997, 65:1489-1494.
3. Keli S.O., Hertog M.G.L., Feskens E.J.M., Kromhout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke - the Zutphen Study. Arch Intern Med 1996, 156:637-642.
4. Frank J., George T.W., Lodge J.K., Rodriguez-Mateos A.M., Spencer J.P., Minihane A.M., et al. Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. J Nutr 2009, 139:58-62.
5. Princen H.M.G., van Duyvenvoorde W., Buytenhek R., Blonk C., Tijburg L.B.M., Langius J.A.E., et al. No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscler Thromb Vasc 1998, 18:833-841.
6. Puglia C., Blasi P., Rizza L., Schoubben A., Bonina F., Rossi C., et al. Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation. Int J Pharm 2008, 357:295-304.
7. Torchilin V.P. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res 2007, 24:1-16.
8. Eccleston G. Emulsions and microemulsions 2002, Vol 2. Encyclopedia of pharmaceutical technology, New York. 2nd ed.
9. Singleton V.L., Rossi J.A. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Vitic 1965, 16:144-158.
10. Park Y.K., Koo M.H., Ikegaki M., Contado J.L. Comparison of the flavonoid aglycone contents of Apis mellifera propolis from various regions of Brazil. Arq Biol Tecnol 1997, 40:97-106.
11. van den Berg R., Haenen G.R.M.M., van den Berg H., Bast A. Applicability of an improved trolox equivalent antioxidant capacity (TEAC) assay for evaluation of antioxidant capacity measurements of mixtures. Food Chem 1999, 66:511-517.
12. Wang H., Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 1999, 27:612-616.
13. Kim D.O., Lee K.W., Lee H.J., Lee C.Y. Vitamin C equivalent antioxidant capacity (VCEAC) of phenolic phytochemicals. J Agric Food Chem 2002, 50:3713-3717.
14. Constantinides P.P., Tustian A., Kessler D.R. Tocol emulsions for drug solubilization and parenteral delivery. Adv Drug Deliv Rev 2004, 56:1243-1255.
15. Payet B., Sing A.S.C., Smadja J. Comparison of the concentrations of phenolic constituents in cane sugar manufacturing products with their antioxidant activities. J Agric Food Chem 2006, 54:7270-7276.
16. Satoh E., Tohyama N., Nishimura M. Comparison of the antioxidant activity of roasted tea with green, oolong, and black teas. Int J Food Sci Nutr 2005, 56:551-559.
17. Sun W.Q., Wang H.F., Xie C.S., Hu Y., Yang X.L., Xu H.B. An attempt to directly trace polymeric nanoparticles in vivo with electron microscopy. J Control Release 2006, 115:259-265.
18. Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 2001, 47:65-81.
19. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232:34-47.
20. Goldstein J.L., Brown M.S., Anderson R.G.W., Russell D.W., Schneider W.J. Receptor-mediated endocytosis - concepts emerging from the LDL receptor system. Annu Rev Cell Biol 1985, 1:1-39.
21. Berliner J.A., Navab M., Fogelman A.M., Frank J.S., Demer L.L., Edwards P.A., et al. Atherosclerosis - basic mechanisms - oxidation, inflammation, and genetics. Circulation 1995, 91:2488-2496.
22. Devika P.T., Stanely Mainzen Prince P. Preventive effect of (-)epigallocatechin gallate on lipids, lipoproteins, and enzymes of lipid metabolism in isoproterenol-induced myocardial infarction in rats. J Biochem Mol Toxicol 2009, 23:387-393.
23. Shafiq S., Shakeel F., Talegaonkar S., Ahmad F.J., Khar R.K., Ali M. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm 2007, 66:227-243.
24. Kotyla T., Kuo F., Moolchandani V., Wilson T., Nicolosi R. Increased bioavailability of a transdermal application of a nano-sized emulsion preparation. Int J Pharm 2008, 347:144-148.
25. Kuo F., Subramanian B., Kotyla T., Wilson T.A., Yoganathan S., Nicolosi R.J. Nanoemulsions of an anti-oxidant synergy formulation containing gamma tocopherol have enhanced bioavailability and anti-inflammatory properties. Int J Pharm 2008, 363:206-213.